VICP
Vicapsys Life Sciences, Inc.
Key Financials
Operating Income
$-1046978
↓ 6.3%
Net Income
$-1182112
↓ 20.0%
Total Assets
$39656.00
↓ 44.9%
EPS (Diluted)
$-0.03
0.0%
Cash & Equivalents
$9422.00
↓ 33.2%
Shareholders' Equity
$-1928681.00
↓ 102.9%
Operating Cash Flow
$-417524.00
↓ 75.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 15-12G | 3/27/2025 | View on SEC |
| SCHEDULE 13G | 3/21/2025 | View on SEC |
| 3 | 3/21/2025 | View on SEC |
| 10-Q | 1/10/2025 | View on SEC |
| 10-Q | 1/10/2025 | View on SEC |
| 10-Q | 1/10/2025 | View on SEC |
| 10-K | 10/21/2024 | View on SEC |
| SEC STAFF ACTION | 6/27/2024 | View on SEC |
| 8-K | 12/27/2023 | View on SEC |
| 10-Q | 11/14/2023 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | VICP |
| Company Name | Vicapsys Life Sciences, Inc. |
| CIK | 1468639 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | FL |
| Phone | 470-514-4013 |